Justin James Mclarney is the Chief Fin. Officer at Nemaura Medical Inc.
As the Chief Fin. Officer of Nemaura Medical Inc, the total compensation of Mr Mclarney at Nemaura Medical Inc is $124,505. There are no executives at Nemaura Medical Inc getting paid more.
Mr Mclarney is 49, he's been the Chief Fin. Officer of Nemaura Medical Inc since . There are 2 older and 5 younger executives at Nemaura Medical Inc. The oldest executive at Nemaura Medical Inc is Thomas Moore, 55, who is the Independent Director.
Justin's mailing address filed with the SEC is C/O NEMAURA MEDICAL INC., 57 WEST 57TH STREET, MANHATTAN, NY, 10019.
Over the last 7 years, insiders at Nemaura Medical Inc have traded over $0 worth of Nemaura Medical Inc stock and bought 100,000 units worth $14,000 . The most active insiders traders include Arash Ghadar Ghadr. On average, Nemaura Medical Inc executives and independent directors trade stock every 0 days with the average trade being worth of $3,000. The most recent stock trade was executed by Arash Ghadar Ghadr on 5 January 2024, trading 100,000 units of NMRD stock currently worth $14,000.
nemaura medical inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. the company provides sugarbeat, a non-invasive continuous glucose monitoring device for use by persons with type i and type ii diabetes, as well as for screening pre-diabetic patients. it has a license agreement with healthimation, llc, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for type 2 diabetes, prediabetes, and general wellness; the why wait app; and common law trademarks which incorporate the mark why wait or whywait and the use of licensed marks. nemaura medical inc. was founded in 2009 and is based in new york, new york.
Nemaura Medical Inc executives and other stock owners filed with the SEC include: